1
|
Tresiba® (insulin degludec injection), Novo Nordisk Canada Inc., Product Monograph, August 25, 2017. |
2 |
Haahr H, Heise T. A review of the pharmacological properties of insulin degludec and their clinical relevance. Clin Pharmacokinet. 2014; 53:787-800. |
3
|
Marso SP, McGuire DK, Zinman B, et al. Efficacy and safety of degludec versus glargine in type 2 diabetes. N Eng J Med. 2017. DOI: 10.1056/NEJMoa1615692. |
4 |
McNay E Coterio V. Mini Review: Impact of recurrent hypoglycemia on cognitive and brain function. Physiol Behav. 2010 June 1; 100(3): 234–238. |
5
|
Diabetes Canada. Canadian Diabetes Association Clinical Practice Guidelines – Hypoglycemia. Accessed August 2017. Available at http://www.canadianjournalofdiabetes.com/article/S1499-2671(13)00023-3/pdf. |
6 |
Inkster B. The Effects of Acute Hypoglycaemia on Cognitive Function in Type 1 Diabetes. British Journal of Diabetes and Vascular Disease. 2012;12(5):221-226 |
7
|
Seaquest E, et al. Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society. Diabetes Care. published online April 15, 2013. |
8 |
Diabetes Canada. Low's & Highs: Blood Sugar Levels. Accessed August 2017. Available at http://www.diabetes.ca/diabetes-and-you/healthy-living-resources/blood-glucose-insulin/lows-highs-blood-sugar-levels. |
9
|
Harris, S., Mamdani, M., Galbo-Jørgensen, C. B., Bøgelund, M., Gundgaard, J., & Groleau, D. (2014). The effect of hypoglycemia on health-related quality of life: Canadian results from a multinational time trade-off survey. Canadian journal of diabetes, 38(1), 45-52. |
10
|
Shafiee G, Mohajeri-Tehrani M, Pajouhi M, Larijani B. J Diabetes Metab Disord. 2012; 11: 17. Published online 2012 October 1. doi: 10.1186/2251-6581-11-17 |
11
|
Brunton SA, Nocturnal hypoglycemia: answering the challenge with long-acting insulin analogs. MedGenMed. 2007 May 17;9(2):38. Accessed August 2017. Available at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1994862/. |
12
|
Lopez JM, Annunziata K, et al. Impact of hypoglycemia on patients with type 2 diabetes mellitus and their quality of life, work productivity, and medication adherence. Patient Prefer Adherence. 2014 May 8;8:683-92 |